Bundy D, Sher A, Michael E, 2000. Good worms or bad worms: do worm infections affect the epidemiological patterns of other diseases? Parasitol Today 16: 273–274.
Karanja DMS, Colley DG, Nahlen BL, Ouma JH, Secor WE, 1997. Studies on schistosomiasis in western Kenya. I. Evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus co-infections. Am J Trop Med Hyg 56: 515–521.
Fontanet AL, Woldemichael T, Sahlu T, 2000. Epidemiology of HIV and Schistosoma mansoni infections among sugar-estate residents in Ethiopia. Ann Trop Med Parasitol 94: 145–155.
N'Zoukoudi-N'Doundou MY, Dirat I, Akouala JJ, Penchenier L, Makuwa M, Rey JL, 1995. Bilharziasis and human immunodeficiency virus infection in Congo. Med Trop (Mars) 55: 249–251.
Mwanakasale V, Vounatsou P, Sukwa TY, Ziba M, Ernest A, Tanner M, 2003. Interactions between Schistosoma haematobium and human immunodeficiency virus type 1: the effects of coinfection on treatment outcomes in rural Zambia. Am J Trop Med Hyg 69: 420–428.
Kallestrup P, Zinyama R, Gomo E, Butterworth AE, van Dam GJ, Erikstrup C, Ullum H, 2005. Schistosomiasis and HIV-1 infection in rural Zimbabwe: implications of coinfection for excretion of eggs. J Infect Dis 191: 1311–1320.
Opisa S, Odiere MR, Jura WGZO, Karanja DMS, Mwinzi PNM, 2011. Malacological survey and geographical distribution of vector snails for schistosomiasis within informal settlements of Kisumu City, western Kenya. Parasit Vectors 4: 226.
Katz N, Chaves A, Pellegrino J, 1972. A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 14: 397–400.
Shane HL, Verani JR, Abudho B, Montgomery SP, Blackstock AJ, Mwinzi PMN, Butler SE, Karanja DMS, Secor WE, 2011. Evaluation of urine CCA assays for detection of Schistosoma mansoni infection in Western Kenya. PLoS Negl Trop Dis 5: e951.
Turner JD, Narang P, Coles MC, Mountford AP, 2012. Blood flukes exploit Peyer's Patch lymphoid tissure to facilitate transmission from the mammalian host. PLoS Pathog 8: e1003063.
Karanja DMS, Boyer AE, Strand M, Colley DG, Nahlen BL, Ouma JH, Secor WE, 1998. Studies on schistosomiasis in western Kenya. II. Efficacy of praziquantel for schistosomiasis patients with human immunodeficiency virus co-infections. Am J Trop Med Hyg 59: 307–311.
Mwinzi PN, Karanja DM, Kareko I, Magak PW, Orago AS, Colley DG, Secor WE, 2004. Short report: evaluation of hepatic fibrosis in persons co-infected with Schistosoma mansoni and human immunodeficiency virus 1. Am J Trop Med Hyg 71: 783–786.
de Silva S, Walsh J, Brown M, 2006. Symptomatic Schistosoma mansoni infection as an immune restoration phenomenon in a patient receiving antiretroviral therapy. Clin Infect Dis 42: 303–304.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 1646 | 1582 | 384 |
Full Text Views | 412 | 12 | 1 |
PDF Downloads | 71 | 12 | 1 |
Previously, we have shown that persons with human immunodeficiency virus 1 (HIV-1) infection and reduced CD4+ T-lymphocyte counts excrete significantly fewer Schistosoma mansoni eggs than HIV-1–negative persons with similar intensities of schistosome infections. To determine how antiretroviral therapy (ART) might affect egg excretion, we conducted a study of HIV+ adults living in an area highly endemic for S. mansoni as they began an ART program. Fecal egg excretion and CD4+ T-lymphocyte counts were evaluated at enrollment as well as 2 and 4 weeks after initiation of ART. Fourteen individuals who were Kato–Katz-negative at enrollment subsequently started excreting S. mansoni eggs accompanied by a significant increase in CD4+ T lymphocytes (P = 0.004). Study participants who were S. mansoni egg-positive at enrollment and received both praziquantel and ART also showed significantly increased CD4+ T-lymphocyte counts compared with baseline (P < 0.0001). Our data support a role for CD4+ T lymphocytes in S. mansoni egg excretion.
Financial support: This research was supported by an European and Developing Countries Clinical Trial Partnership Senior Fellowship awarded to P.N.M.M.
Authors' addresses: Erick M. O. Muok, Elizabeth A. Ochola, Diana M. S. Karanja, and Pauline N. M. Mwinzi, Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya, E-mails: EMuok@kemricdc.org, EAkinyi@kemricdc.org, DKaranja@kemricdc.org, and PMwinzi@kemricdc.org. Elses W. Simiyu, Zoology Department, Maseno University, Maseno, Kenya, E-mail: elsessim@yahoo.com. Zipporah W. Ng'ang'a, Department of Health Sciences, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya, E-mail: zipnganga@gmail.com. W. Evan Secor, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA, E-mail: was4@cdc.gov.
Bundy D, Sher A, Michael E, 2000. Good worms or bad worms: do worm infections affect the epidemiological patterns of other diseases? Parasitol Today 16: 273–274.
Karanja DMS, Colley DG, Nahlen BL, Ouma JH, Secor WE, 1997. Studies on schistosomiasis in western Kenya. I. Evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus co-infections. Am J Trop Med Hyg 56: 515–521.
Fontanet AL, Woldemichael T, Sahlu T, 2000. Epidemiology of HIV and Schistosoma mansoni infections among sugar-estate residents in Ethiopia. Ann Trop Med Parasitol 94: 145–155.
N'Zoukoudi-N'Doundou MY, Dirat I, Akouala JJ, Penchenier L, Makuwa M, Rey JL, 1995. Bilharziasis and human immunodeficiency virus infection in Congo. Med Trop (Mars) 55: 249–251.
Mwanakasale V, Vounatsou P, Sukwa TY, Ziba M, Ernest A, Tanner M, 2003. Interactions between Schistosoma haematobium and human immunodeficiency virus type 1: the effects of coinfection on treatment outcomes in rural Zambia. Am J Trop Med Hyg 69: 420–428.
Kallestrup P, Zinyama R, Gomo E, Butterworth AE, van Dam GJ, Erikstrup C, Ullum H, 2005. Schistosomiasis and HIV-1 infection in rural Zimbabwe: implications of coinfection for excretion of eggs. J Infect Dis 191: 1311–1320.
Opisa S, Odiere MR, Jura WGZO, Karanja DMS, Mwinzi PNM, 2011. Malacological survey and geographical distribution of vector snails for schistosomiasis within informal settlements of Kisumu City, western Kenya. Parasit Vectors 4: 226.
Katz N, Chaves A, Pellegrino J, 1972. A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 14: 397–400.
Shane HL, Verani JR, Abudho B, Montgomery SP, Blackstock AJ, Mwinzi PMN, Butler SE, Karanja DMS, Secor WE, 2011. Evaluation of urine CCA assays for detection of Schistosoma mansoni infection in Western Kenya. PLoS Negl Trop Dis 5: e951.
Turner JD, Narang P, Coles MC, Mountford AP, 2012. Blood flukes exploit Peyer's Patch lymphoid tissure to facilitate transmission from the mammalian host. PLoS Pathog 8: e1003063.
Karanja DMS, Boyer AE, Strand M, Colley DG, Nahlen BL, Ouma JH, Secor WE, 1998. Studies on schistosomiasis in western Kenya. II. Efficacy of praziquantel for schistosomiasis patients with human immunodeficiency virus co-infections. Am J Trop Med Hyg 59: 307–311.
Mwinzi PN, Karanja DM, Kareko I, Magak PW, Orago AS, Colley DG, Secor WE, 2004. Short report: evaluation of hepatic fibrosis in persons co-infected with Schistosoma mansoni and human immunodeficiency virus 1. Am J Trop Med Hyg 71: 783–786.
de Silva S, Walsh J, Brown M, 2006. Symptomatic Schistosoma mansoni infection as an immune restoration phenomenon in a patient receiving antiretroviral therapy. Clin Infect Dis 42: 303–304.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 1646 | 1582 | 384 |
Full Text Views | 412 | 12 | 1 |
PDF Downloads | 71 | 12 | 1 |